Vertex Pharma (VRTX) April volatility at 33, July at 47 into ADVANCE trial

March 24, 2010 7:05 AM EDT Send to a Friend

Vertex Pharma (Nasdaq: VRTX) closed at $42.18 VRTX results for telaprevir three ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Vertex Pharma (VRTX) April volatility at 33, July at 47 into ADVANCE trial

Member Login

Free News Feed